Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter, Mary E. Rinella
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1851-1864
Closed Access | Times Cited: 1000

Showing 1-25 of 1000 citing articles:

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1797-1835
Open Access | Times Cited: 1159
The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 400
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
Alessandro Mantovani, Alessandro Csermely, Graziana Petracca, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 11, pp. 903-913
Open Access | Times Cited: 395
From NAFLD to MAFLD: Implications of a Premature Change in Terminology
Zobair M. Younossi, Mary E. Rinella, Arun J. Sanyal, et al.
Hepatology (2020) Vol. 73, Iss. 3, pp. 1194-1198
Closed Access | Times Cited: 361
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson, Brian N. Finck
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 484-495
Open Access | Times Cited: 338
Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial
Samer Gawrieh, Mazen Noureddin, Nicole Loo, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 1809-1824
Open Access | Times Cited: 265
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili, Michael Roden
Molecular Metabolism (2020) Vol. 50, pp. 101122-101122
Open Access | Times Cited: 240
The ménage à trois of autophagy, lipid droplets and liver disease
Yasmina Filali-Mouncef, Catherine J. Hunter, Federica Roccio, et al.
Autophagy (2021) Vol. 18, Iss. 1, pp. 50-72
Open Access | Times Cited: 225
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
Yamei Duan, Xiongfeng Pan, Jiayou Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 220
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige, Kenichi Ikejima, Masafumi Ono, et al.
Journal of Gastroenterology (2021) Vol. 56, Iss. 11, pp. 951-963
Open Access | Times Cited: 206
TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases
Miao Zhang, Yueming Ma, Xianglu Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 196
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Soo Lim, Jin‐Wook Kim, Giovanni Targher
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 7, pp. 500-514
Closed Access | Times Cited: 151
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 138
CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells
Yuzo Koda, Toshiaki Teratani, Po–Sung Chu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 134
Lipid Droplet Contact Sites in Health and Disease
Eva Herker, Gabrielle Vièyres, Mathias Beller, et al.
Trends in Cell Biology (2021) Vol. 31, Iss. 5, pp. 345-358
Open Access | Times Cited: 129
Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study
Shuai Yuan, Jie Chen, Xue Li, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 7, pp. 723-733
Open Access | Times Cited: 129
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
Chandani Patel Chavez, Kenneth Cusi, Sushma Kadiyala
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 1, pp. 29-38
Open Access | Times Cited: 120
Health Promoting Properties of Bee Royal Jelly: Food of the Queens
Nicolas Collazo, María Carpena, Bernabé Núñez-Estévez, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 543-543
Open Access | Times Cited: 119
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige, Kenichi Ikejima, Masafumi Ono, et al.
Hepatology Research (2021) Vol. 51, Iss. 10, pp. 1013-1025
Open Access | Times Cited: 116
Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
Kazuhiro Kozumi, Takahiro Kodama, Hiroki Murai, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2452-2466
Open Access | Times Cited: 111
Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990-2019
Yichen Wang, Yuting Huang, Robert C. Chase, et al.
Gastroenterology (2023) Vol. 165, Iss. 3, pp. 773-783.e15
Closed Access | Times Cited: 87
Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective
Kylynda C. Bauer, Paula Littlejohn, Victòria Ayala, et al.
Gastroenterology (2022) Vol. 162, Iss. 7, pp. 1858-1875.e2
Open Access | Times Cited: 86
MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
Mette Yde Hochreuter, Morten Dall, Jonas T. Treebak, et al.
Molecular Metabolism (2022) Vol. 65, pp. 101581-101581
Open Access | Times Cited: 85
Obesity and Dyslipidemia
Barbora Nussbaumerová, Hana Rosolová
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 12, pp. 947-955
Closed Access | Times Cited: 80
Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review
Narjes Nasiri‐Ansari, Θεόδωρος Ανδρουτσάκος, Christina‐Maria Flessa, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2511-2511
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top